Retrospective and prospective cohort of patients with germ cell tumor in treatment.
The primary objective of this study is to create a multicenter database in order to characterize epidemiologically and clinicopathologically patients with germ cell tumor and evaluate the prognosis and clinical outcomes during cancer treatment.
Study Type
OBSERVATIONAL
Enrollment
1,315
CPO - Pucrs
Porto Alegre, Rio Grande do Sul, Brazil
Hospital Israelita Albert Einstein
São Paulo, Brazil
Hospital São José
São Paulo, Brazil
ICESP
São Paulo, Brazil
Brazilian multicenter database in order to collect and analyze data from diagnosis and treatment of patients with germ cell tumor
Time frame: From 2000 to 2025
Description of demographic characteristics of testicular germ cell tumor patients in Brazil
Time frame: From 2000 to 2025
The clinical and pathological characteristics of testicular germ cell tumor patients in Brazil.
Time frame: From 2000 to 2025
Treatment according to staging and relapse of patients diagnosed with testicular germ cell tumor in Brazil
Time frame: From 2000 to 2025
Disease free survival of patients diagnosed with germ cell tumor stage 1.
Time frame: From 2000 to 2025
Overall survival of patients diagnosed with germ cell tumor stage 1.
Time frame: From 2000 to 2025
Disease free survival of patients diagnosed with germ cell tumor stages 2 and 3.
Time frame: From 2000 to 2025
Overall survival of patients diagnosed with germ cell tumor stages 2 and 3.
Time frame: From 2000 to 2025
International prognostic factors in patients with advanced germ cell tumor (stages 2 and 3) stablished by the International Germ Cell Cancer Collaborative Group in brazilian patients.
Time frame: From 2000 to 2025
Treatment outcome in different populations: in patients with brain metastasis, patients with germinative tumor extragonodal, surgery outcome in patients with nonseminomous tumor and ressection of residual lesion after chemotherapy
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: From 2000 to 2025
Disease free survival of patients diagnosed with disease relapse after first line chemotherapy
Time frame: From 2000 to 2025
Overall survival of patients diagnosed with disease relapse after first line chemotherapy
Time frame: From 2000 to 2025
Prognostic model after first line treatment failure with cisplatin, stablished by the International Prognostic Factors Study Group in brazilian patients.
Time frame: From 2000 to 2025